DUBLIN--(BUSINESS WIRE)--The "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.
The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region.
The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019.
Based on end user, the transplant diagnostics market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the transplant diagnostics market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.
The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019.
The transplant diagnostics market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.
North America accounted for the largest share of the transplant diagnostics market in 2019.
North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Transplant Diagnostics Market Overview
4.2 Market, By Technology
4.3 Regional Analysis: Market, By Application
4.4 Asia Pacific: Market, By End User, 2019
4.5 Regional Analysis: Market, By Product & Service
4.6 Regional Analysis: Market, By Transplant Type
4.7 Market, By Country
5 Market Overview
5.2 Market Dynamics
5.2.1 Key Market Drivers
18.104.22.168 Increasing Number of Transplant Procedures
22.214.171.124 Technological Advancements in the Field of Transplant Diagnostics
126.96.36.199 Increasing Public-Private Funding for Target Research Activities
188.8.131.52 Increasing Prevalence of Infectious Diseases
5.2.2 Key Market Restraints
184.108.40.206 High Procedural Cost of Ngs- and Pcr-Based Diagnostic Assays
220.127.116.11 Limited Reimbursements for Target Procedures
5.2.3 Key Market Opportunities
18.104.22.168 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
22.214.171.124 Growing Public Awareness About Organ Donation and Transplantation
5.2.4 Key Market Challenges
126.96.36.199 Significant Gap Between the Number of Organ Donors and Organs Required Annually
188.8.131.52 Procedural and Technical Limitations Associated With Donor-Recipient Screening
6 Transplant Diagnostics Market, By Technology
6.2 Molecular Assay Technologies
6.2.1 Pcr-Based Molecular Assays
184.108.40.206 Sequence-Specific Oligonucleotide-Pcr
220.127.116.11.1 Sso-Pcr is the Most Widely Adopted Technique in the Pcr-Based Molecular Assays Market
18.104.22.168 Sequence-Specific Primer-Pcr
22.214.171.124.1 Growing Public-Private Investments for Research Activities to Support Market Growth
126.96.36.199 Real-Time Pcr
188.8.131.52.1 Real-Time Pcr Requires Smaller Sample Volumes As Compared to Conventional Pcr Technologies
184.108.40.206 Other Pcr-Based Molecular Assays
6.2.2 Sequencing-Based Molecular Assays
220.127.116.11 Sanger Sequencing
18.104.22.168.1 Sanger Sequencing Segment to Register the Highest Growth in the Sequencing-Based Molecular Assays Market
22.214.171.124 Next-Generation Sequencing
126.96.36.199.1 Low Turnaround Time & High Throughput Sequencing are the Major Factors Supporting the Adoption of Ngs
188.8.131.52 Other Sequencing-Based Molecular Assays
6.3 Non-Molecular Assay Technologies
6.3.1 Replacement of Non-Molecular Assay Techniques With Dna-Based Techniques is Expected to Hamper Market Growth
7 Transplant Diagnostics Market, By Product & Service
8 Transplant Diagnostics Market, By Application
9 Transplant Diagnostics Market, By Transplant Type
9.2 Solid Organ Transplantation
9.2.1 Kidney Transplantation
184.108.40.206 Market Growth is Mainly Driven By Rising Kidney Disease Prevalence
9.2.2 Liver Transplantation
9.2.3 Lung Transplantation
9.2.4 Heart Transplantation
9.2.5 Pancreas Transplantation
9.2.6 Other Organ Transplantations
9.3 Stem Cell Transplantation
9.4 Soft Tissue Transplantation
9.5 Bone Marrow Transplantation
9.5.1 Dearth of Well-Trained Surgeons to Perform Bone Marrow Transplantation is Expected to Hinder Market Growth
10 Transplant Diagnostics Market, By End User
10.2 Independent Reference Laboratories
10.2.1 Rising Consolidation of Diagnostic Laboratories to Drive Market Growth
10.3 Hospitals & Transplant Centers
10.3.1 Growing Purchasing Power of Hospitals & Transplant Centers has Resulted in High Market Growth
10.4 Research Laboratories & Academic Institutes
10.4.1 Growing Awareness About the Genetic Techniques in Transplant Rejection Monitoring to Drive Market Growth
11 Transplant Diagnostics Market, By Region
11.2 North America
220.127.116.11 Ongoing Technological Advancements in the Field of Transplant Diagnostics to Drive Market Growth in the US
18.104.22.168 Growing Availability of Transplant Diagnostic Products to Support Market Growth in Canada
11.4 Asia Pacific
11.5 Latin America
11.6 Middle East & Africa
12 Competitive Landscape
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Product Launches & Enhancements
12.3.2 Agreements, Partnerships, and Collaborations
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies
13 Company Profiles
13.1 Becton, Dickinson and Company
13.3 Biomrieux SA
13.4 Bio-Rad Laboratories
13.6 F. Hoffman-La Roche Limited
13.8 Hologic, Inc.
13.9 Illumina, Inc.
13.10 Immucor, Inc.
13.11 Luminex Corporation
13.12 Merck KGaA
13.14 Qiagen Nv
13.15 Thermo Fisher Scientific
13.16 Emerging Players
13.16.1 Alpha Biotech, Ltd.
13.16.2 Bag Healthcare
13.16.3 Hansa Biopharma AB
13.16.4 Histogenetics LLC
13.16.5 Pacific Biosciences of California, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/jyrmyh